SculpSure vs TruSculpt iD vs Vanquish vs Evolve: Fat Devices Compared

You want to melt stubborn abdominal, flank, or chin fat without surgery or freezing, and several clinics keep pitching SculpSure, TruSculpt iD, Vanquish, and Evolve—all claiming an average of ~24% fat reduction. Which technology is which, what did the FDA actually clear, and do any of these devices truly beat the others?

These four popular non-invasive body contouring devices are all FDA 510(k)-cleared Class II medical platforms, but they utilize different energy types and operate under distinct regulatory classifications. SculpSure (Cynosure, K150230) is a 1060 nm laser and is the only device of the four cleared under a fat-specific regulation (PKT / 21 CFR 878.5400, "Laser for Disruption of Adipocyte Cells"). In contrast, TruSculpt iD (Cutera, K223110), Vanquish (BTL, K152731), and Evolve (InMode, K210877) are radiofrequency (RF) devices cleared under the general electrosurgical regulation (21 CFR 878.4400) — TruSculpt iD and Vanquish under product code GEI, Evolve under product code PBX — for tissue heating and remodeling.

While SculpSure and TruSculpt iD both report ~24% average fat reduction, they use different measurement methods (MRI volume vs. ultrasound thickness). Vanquish ME’s peer-reviewed efficacy shows a ~5 mm thickness reduction over four sessions (Hayre 2016), rather than the unsourced "25% to 30%" claims seen on clinic sites. Evolve's fat-reduction data is the thinnest of the four, as the platform is primarily cleared for skin and tissue remodeling.

Expect to undergo 1 to 6 sessions depending on the device, with a real-world cost ranging from $500 to $1,800 per session ($2,000 to $5,000 total). Our review of the FDA MAUDE database revealed 62 adverse event reports for SculpSure (2016–2024), consisting of 60 injuries (burns and skin nodules) and one malfunction. While these heat-based devices permanently destroy fat cells in the treated zone, results require a stable baseline weight to remain visible.

---

Laser vs. radiofrequency: how does each device actually destroy fat?

Non-invasive fat reduction using heat relies on raising the temperature of subcutaneous adipose tissue to between 42°C and 47°C for a sustained period. This thermal window triggers hyperthermic cellular injury, leading to adipocyte apoptosis (programmed cell death). Over the following 6 to 12 weeks, the body's lymphatic system metabolizes and clears the damaged adipocytes. However, the physical pathways used to generate this heat differ between lasers and radiofrequency.

SculpSure: 1060 nm Laser Hyperthermia

SculpSure utilizes a 1060 nm diode laser. The 1060 nm wavelength is selected because it has a high absorption coefficient in adipose tissue and low absorption in melanin and water. This allows the laser energy to pass through the skin surface with minimal absorption, concentrating its thermal energy in the subcutaneous fat layer.

During a 25-minute treatment, four flat applicators are strapped to the target area (such as the abdomen or flanks). The laser cycles on and off to heat the fat layer while contact cooling pads protect the epidermis. The temperature of the fat tissue is raised to between 42°C and 47°C. The mechanical structure of the applicators is completely stationary, making the heat delivery uniform across the treatment grid.

TruSculpt iD: 2 MHz Monopolar Radiofrequency

TruSculpt iD uses 2 MHz monopolar radiofrequency energy. Unlike laser energy, which relies on light absorption, RF energy relies on electrical impedance. Adipose tissue has high electrical resistance compared to skin and muscle. When RF current passes through the subcutaneous layer, the resistance causes the fat tissue to heat up rapidly (Joule heating).

TruSculpt iD features six hands-free applicators that are placed over the treatment area. The device continuously measures the skin temperature and adjusts the RF power dynamically to maintain a skin temperature of ~43°C to 44°C, which heats the underlying fat to therapeutic levels (~45°C) within a 15-minute session. The monopolar configuration allows the energy to penetrate deeply into the fat layer.

Vanquish ME: Contactless Selective RF Field

Vanquish ME (Maximum Energy) utilizes a high-frequency, contactless RF field. The applicator is positioned over the abdomen and flanks without directly touching the patient's skin.

The device emits RF energy at a frequency of 27.12 MHz. This frequency is tuned to match the impedance of subcutaneous fat tissue. The energy passes through the air gap and the epidermis, heating the fat layer selectively while sparing the muscle and skin. Because the applicator covers a large, curved surface area (from flank to flank), Vanquish ME can treat the entire abdomen in a single 45-minute session.

InMode Evolve: Bipolar RF and Vacuum

The Evolve platform is a multi-modular hands-free workstation that uses bipolar RF energy. It features three distinct applicator types:

1. Evolve Tite: Bipolar RF applicators designed for skin remodeling and tightening.
2. Evolve Trim: Bipolar RF applicators combined with a gentle vacuum. The vacuum pulls a pocket of subcutaneous fat between two electrodes, delivering a high-voltage pulse to disrupt the adipocyte membranes (electroporation) alongside thermal heating.
3. Evolve Tone: Uses electrical muscle stimulation to tone muscles (similar to TruSculpt flex).

The bipolar configuration limits the depth of the RF current path to the distance between the two electrodes on the applicator, making Evolve more superficial than the monopolar TruSculpt iD or the contactless Vanquish field.

---

What did the FDA clear each device for (K-number, product code, regulation)?

The regulatory profile of these platforms outlines how the U.S. Food and Drug Administration (FDA) evaluates heat-based body contouring. The key regulatory detail is the difference between a fat-specific product clearance and a general electrosurgical tissue-heating clearance.

The Fat-Specific Regulation (PKT) vs. General Electrosurgical Regulation (GEI)

• Product Code PKT (Laser for Disruption of Adipocyte Cells): Regulated under 21 CFR 878.5400. This regulation is reserved specifically for devices that prove clinical efficacy in destroying fat cells using laser energy.
• Product Code GEI / PBX (Electrosurgical Device): Regulated under 21 CFR 878.4400. This is a broad category covering cutting, coagulation, and tissue ablation/remodeling using radiofrequency. TruSculpt iD and Vanquish clear under product code GEI; Evolve clears under PBX ("massager, vacuum, radio frequency induced heat"). Many RF devices enter this category as tissue-heating tools, then market fat-reduction benefits using clinical studies, even though their primary FDA clearance is for general electrosurgical tissue remodeling.

Let's review the specific 510(k) clearances and cleared indications for each device:

Cynosure's SculpSure Clearance Chain

SculpSure has a robust regulatory history, with 6 distinct FDA 510(k) clearances in its product chain, all verified under product code PKT:

1. K150230 (2015-05-15): Original clearance for non-invasive lipolysis of the flanks.
2. K150724 (2015-07-01): Clearance expanded to include the abdomen.
3. K160470 (2016-07-21): Clearance for expanded applicator placement grids.
4. K171111 (2017-06-13): Clearance for treatment of the thighs and back.
5. K171992 (2017-09-26): Clearance for the submental (under-chin) area.
6. K182741 (2019-01-03): Clearance for the treatment of upper arms.

Device Identity Clarification

A common error in clinic literature is mixing up BTL's devices. Many sites state that BTL's Emsculpt Neo is the same platform as Vanquish.

They are separate:

• BTL-899 (K192224): This is the Emsculpt Neo platform, which combines HIFEM muscle stimulation with RF. It is classified under product code NGX (powered muscle stimulator).
• BTL XP1100 RF (K152731): This is the Vanquish/Vanquish ME platform, which is a contactless RF field classified under product code GEI.

For patients comparing options, understanding these regulatory codes helps clarify what a device was clinically proven to do during its FDA review. To compare these heat-based technologies with cold-based platforms, see our guide on CoolSculpting cost and its associated CoolSculpting MAUDE adverse events digest.

---

How effective are they — and why do they all claim ~24%?

The "~24% average fat reduction" claim is widely used in body contouring marketing. However, this number represents different measurement methods across the devices:

The Measurement Gap: MRI vs. Ultrasound

• SculpSure's 24% Claim: Cynosure's pivotal clinical trials measured fat loss using Magnetic Resonance Imaging (MRI) to assess volumetric changes in the subcutaneous layer. The 24% figure represents the average reduction in fat volume within the treated area after a single session.
• TruSculpt iD's 24% Claim: Cutera's clinical trials measured fat loss using high-resolution ultrasound. The 24% figure represents the average reduction in fat layer thickness (in millimeters) after a single session.
• The Volumetric vs. Linear Difference: A 24% reduction in volume (MRI) is not mathematically equivalent to a 24% reduction in thickness (ultrasound). Volume measurements reflect a three-dimensional change, whereas thickness reflects a one-dimensional measurement. Therefore, these percentage figures cannot be directly compared.

Peer-Reviewed Imaging Data: Decorato (2017) and the 1060 nm Clinical Program

The published literature on SculpSure provides more conservative, concrete numbers than the headline percentage. In the peer-reviewed clinical study by Decorato and colleagues in Lasers in Surgery and Medicine (2017) — part of the same 1060 nm clinical program reported by Bass and Katz at ASLMS — ultrasound imaging was used to quantify what the laser actually does to the fat layer:

• Methodology: Subjects received a single 1060 nm laser treatment on the abdomen or flanks, with results imaged at 12 weeks.
• Efficacy: The average reduction in adipose tissue thickness measured by ultrasound was on the order of 2.6 mm (± roughly 1.4 mm) per session — the real-world figure behind the "24%" MRI volume claim.
• Real-World Context: While ~2.6 mm is statistically significant on imaging, its cosmetic impact depends on the patient's baseline fat thickness. For a patient with a 4 cm fat layer, a 2.6 mm reduction is subtle. For a patient with a 1.5 cm layer, a 2.6 mm reduction is more noticeable.

The Vanquish ME Evidence: Hayre (2016)

Many clinic sites claim that Vanquish ME achieves "25% to 30% fat loss." This number is not supported by peer-reviewed studies. In the independent clinical trial published by Hayre et al. in the Journal of Drugs in Dermatology (PMID 28095578):

• Methodology: 15 subjects received four weekly Vanquish treatments on the abdomen.
• Efficacy: The average reduction in abdominal fat thickness measured by ultrasound was ~5.0 mm at 4 weeks post-treatment.
• Clinical Takeaway: Rather than a percentage, the physical reduction was a half-centimeter of thickness. This represents a realistic cosmetic outcome for contactless RF treatments.

Evolve's Efficacy Profile

For InMode Evolve, independent, peer-reviewed clinical studies showing average fat reduction percentages are limited. The system is cleared primarily under the electrosurgical code (PBX, 21 CFR 878.4400) for skin tightening and tissue remodeling. While it can reduce fat thickness using its Trim applicator (which uses RF and vacuum), the clinical data supporting its fat-reduction efficacy is less extensive than the clinical programs developed for SculpSure or TruSculpt iD.

---

What do the MAUDE adverse-event reports actually show (SculpSure)?

Heat-based fat reduction is non-invasive, but raising tissue temperatures to 47°C carries risks. The FDA's MAUDE database provides a record of these clinical safety signals.

The 62-Report SculpSure Digest

Our review of the FDA MAUDE database identified 62 adverse event reports specifically associated with the Cynosure SculpSure platform (brand name SculpSure, manufacturer Cynosure) dated between June 15, 2016, and March 22, 2024 (a June 2026 extract; the broader PKT product-code family holds 72 reports, 64 of them listed under manufacturer Cynosure):

• Total Reports: 62
• Classification:
  • Injury: 60 reports
  • Malfunction: 1 report
  • Other / Unclassified: 1 report
• Reporting Source:
  • Manufacturer-Submitted: 49 reports
  • Voluntary-Submitted: 13 reports

Analysis of the Injury Reports

The narratives within these 60 injury reports reveal a consistent pattern of thermal complications:

1. Thermal Burns (First and Second Degree): The most frequent complication. These burns occur under the flat laser applicators. They are often caused by poor contact between the applicator's cooling plate and the skin, sweat pooling under the applicator frame (which refracts the laser light), or incorrect placement over bony prominences.
2. Skin Blistering and Hyperpigmentation: Secondary to the thermal burns, requiring several weeks of topical wound care.
3. Subcutaneous Nodules / Induration: Hard, painful lumps that develop in the treated fat layer. These represent areas of fat necrosis (dead fat cells) that have clustered together. While they typically resolve spontaneously over 3 to 6 months with gentle massage, they can cause anxiety for patients who mistake them for permanent tissue damage.
4. Persistent Erythema and Edema: Redness and swelling that persists beyond the typical 24-to-48-hour recovery window.

Safety Contrast: No Paradoxical Adipose Hyperplasia (PAH)

A key safety distinction between heat-based devices (SculpSure, TruSculpt iD, Vanquish) and cold-based devices (CoolSculpting) is the risk of Paradoxical Adipose Hyperplasia (PAH).

PAH is a serious complication of cryolipolysis where the treated fat tissue undergoes rapid expansion, hardening into a firm mass resembling the shape of the applicator. The manufacturer-reported incidence of PAH with CoolSculpting is roughly 1 in 3,000 to 1 in 4,000 treatment cycles, though independent multicenter reviews have reported higher rates.

To date, PAH is not a recognized risk for heat-based devices. Because hyperthermic energy destroys fat cells without stimulating the reactive hyperplasia seen with tissue freezing, patients seeking to avoid the risk of PAH often choose laser or RF body contouring. For a comparison of tissue injury profiles, see our analysis of CoolSculpting PAH risk.

---

How many sessions, what does it cost, and does the fat come back?

Patients considering these treatments must evaluate the clinical protocol, total cost, and long-term durability of the results.

Session Protocols

• SculpSure: Typically requires 1 to 2 sessions per area, spaced 6 to 12 weeks apart.
• TruSculpt iD: Often marketed as a single-session treatment, though a subset of patients require a second session at 12 weeks for optimal results.
• Vanquish ME: Requires a series of 4 to 6 sessions, spaced 1 week apart.
• Evolve Trim: Requires a series of 6 to 8 sessions, performed weekly.

Real-World Cost Breakdown

Aesthetic treatments are priced by the number of applicators used (the "area") and the session count.

Note: The national average cost for non-surgical fat reduction reported by the American Society of Plastic Surgeons (ASPS) is approximately $1,157.

Durability of Fat Reduction

A common question is: "Does the fat come back?"

The biological answer is no. Humans develop a fixed number of fat cells during adolescence. Once we reach adulthood, weight gain causes existing fat cells to expand, while weight loss causes them to shrink.

Heat-based devices permanently destroy a portion of the fat cells in the treated zone (via apoptosis). These cells are cleared from the body and cannot regenerate. However, the remaining fat cells in the area can still expand if the patient experiences weight gain. Therefore, maintaining a stable weight and healthy lifestyle is essential to preserve the cosmetic outcome.

Market Context: The ASPS Volume Trends

According to the American Society of Plastic Surgeons (ASPS) 2023 statistics:

• Total Non-Invasive Fat Reduction Procedures: 745,967 procedures in the U.S.
• Year-over-Year Growth: A 9% increase from 682,932 procedures in 2022.
• Methodology Caveat: Some industry reports from 2024 claim a decline in non-surgical volume. However, these figures are based on member-surgeon counts and do not track the med spas and dermatology offices where the majority of non-surgical treatments are performed. The overall demand for non-surgical body contouring remains high.

---

Heat-Based Fat Reduction Platforms Compared

This comparison table summarizes the technical specifications, clearances, and clinical protocols for the four devices:

---

FAQ: Common questions answered

Is SculpSure FDA-approved or just FDA-cleared?

SculpSure is FDA-cleared, not FDA-approved. This is a common terminology error in medical spa marketing. In the U.S., Class II devices (such as lasers and RF systems) undergo the 510(k) clearance process. This requires proving the device is "substantially equivalent" to a legally marketed predicate device. FDA approval is reserved for Class III high-risk or life-sustaining devices (like pacemakers and breast implants) which require extensive pre-market clinical trials.

How many SculpSure or TruSculpt iD sessions do I need?

• SculpSure: Most patients require 1 to 2 sessions per area to achieve visible results, spaced 6 to 12 weeks apart.
• TruSculpt iD: Often marketed as a single-session treatment, though patients with thicker adipose tissue may require a second session.

Does the fat come back after non-invasive fat reduction?

No. The fat cells destroyed during the treatment are permanently eliminated. However, the remaining fat cells in the treated area can still expand if you experience weight gain. Maintaining a stable weight is essential to preserve your results.

Which hurts least — SculpSure, TruSculpt iD, Vanquish, or Evolve?

• Vanquish ME is generally considered the most comfortable, as it does not make direct contact with the skin and heats the tissue gradually.
• TruSculpt iD feels like a hot stone massage, with manageable discomfort.
• Evolve Trim feels warm, but the suction vacuum can cause mild pinching.
• SculpSure is typically described as the most uncomfortable. The laser cycles between intense heat and cooling, which can cause a deep, cramping sensation.

What is the difference between these and CoolSculpting?

• Mechanism: CoolSculpting uses cold (cryolipolysis) to freeze fat cells, while SculpSure, TruSculpt iD, Vanquish, and Evolve use heat (laser or RF) to destroy them.
• Safety Profile: Heat-based devices do not carry the risk of Paradoxical Adipose Hyperplasia (PAH), which is a rare mass-expansion complication associated with CoolSculpting.
• Downtime: Both approaches are non-surgical with no downtime, but CoolSculpting patients can experience temporary post-treatment numbness that lasts for several weeks.

---

Sources

• FDA 510(k) Summary K150230. SculpSure Device. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K150230
• FDA 510(k) Summary K223110. truSculpt iD. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/cdrh_docs/pdf22/K223110.pdf
• FDA 510(k) Summary K152731. BTL XP1100 RF (Vanquish ME). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152731.pdf
• FDA 510(k) Summary K210877. InMode Evolve. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/cdrh_docs/pdf21/K210877.pdf
• Hayre N, et al. Clinical evaluation of a contactless selective radiofrequency device for non-invasive abdominal fat reduction. Journal of Drugs in Dermatology. 2016;15(12):1551-1555. https://pubmed.ncbi.nlm.nih.gov/28095578/
• Decorato JW, Chen B, Sierra R. Subcutaneous adipose tissue response to a non-invasive hyperthermic treatment using a 1060 nm laser. Lasers in Surgery and Medicine. 2017;49(5):480-489. doi:10.1002/lsm.22625.
• Non-Invasive Body Contouring Technologies: Safety and Efficacy Overview. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/non-invasive-body-contouring-technologies
• Cynosure LLC. SculpSure Clinical Monograph and Provider Guide. https://www.cynosure.com/product/sculpsure/